Clinical evaluation of tumor-associated trypsin inhibitor (TATI): proceedings of a symposium held in Barcelona on September 24, 1989
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Oxford u.a.
Blackwell Scientific Publ.
1991
|
Schriftenreihe: | The Scandinavian journal of clinical and laboratory investigation / Supplement
207 |
Schlagworte: | |
Beschreibung: | Literaturangaben |
Beschreibung: | 73 S. graph. Darst. |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV004636761 | ||
003 | DE-604 | ||
005 | 19920325 | ||
007 | t | ||
008 | 911204s1991 d||| |||| 10||| engod | ||
035 | |a (OCoLC)58503305 | ||
035 | |a (DE-599)BVBBV004636761 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-12 |a DE-19 |a DE-20 |a DE-91 |a DE-355 |a DE-29 | ||
080 | |a 57 | ||
080 | |a 616 | ||
084 | |a YV 1505 |0 (DE-625)154214:12911 |2 rvk | ||
084 | |a CHE 820f |2 stub | ||
084 | |a MED 335f |2 stub | ||
084 | |a CHE 890f |2 stub | ||
084 | |a MED 321f |2 stub | ||
245 | 1 | 0 | |a Clinical evaluation of tumor-associated trypsin inhibitor (TATI) |b proceedings of a symposium held in Barcelona on September 24, 1989 |c ed. Ulf-Håkan Stenman ... |
264 | 1 | |a Oxford u.a. |b Blackwell Scientific Publ. |c 1991 | |
300 | |a 73 S. |b graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a The Scandinavian journal of clinical and laboratory investigation / Supplement |v 207 | |
500 | |a Literaturangaben | ||
650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Tumorantigen |0 (DE-588)4186425-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Tumorassoziierter Trypsininhibitor |0 (DE-588)4275475-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Tumor |0 (DE-588)4078460-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Trypsininhibitor |0 (DE-588)4186358-6 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1989 |z Barcelona |2 gnd-content | |
689 | 0 | 0 | |a Tumorassoziierter Trypsininhibitor |0 (DE-588)4275475-6 |D s |
689 | 0 | 1 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Tumor |0 (DE-588)4078460-5 |D s |
689 | 1 | 1 | |a Trypsininhibitor |0 (DE-588)4186358-6 |D s |
689 | 1 | |5 DE-604 | |
689 | 2 | 0 | |a Tumorantigen |0 (DE-588)4186425-6 |D s |
689 | 2 | 1 | |a Trypsininhibitor |0 (DE-588)4186358-6 |D s |
689 | 2 | |5 DE-604 | |
700 | 1 | |a Stenman, Ulf-Håkan |e Sonstige |4 oth | |
810 | 2 | |a Supplement |t <<The>> Scandinavian journal of clinical and laboratory investigation |v 207 |w (DE-604)BV000003737 |9 207 | |
999 | |a oai:aleph.bib-bvb.de:BVB01-002846331 |
Datensatz im Suchindex
_version_ | 1804118755582672896 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV004636761 |
classification_rvk | YV 1505 |
classification_tum | CHE 820f MED 335f CHE 890f MED 321f |
ctrlnum | (OCoLC)58503305 (DE-599)BVBBV004636761 |
discipline | Chemie Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02120nam a2200541 cb4500</leader><controlfield tag="001">BV004636761</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19920325 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">911204s1991 d||| |||| 10||| engod</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)58503305</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV004636761</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-355</subfield><subfield code="a">DE-29</subfield></datafield><datafield tag="080" ind1=" " ind2=" "><subfield code="a">57</subfield></datafield><datafield tag="080" ind1=" " ind2=" "><subfield code="a">616</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YV 1505</subfield><subfield code="0">(DE-625)154214:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">CHE 820f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 335f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">CHE 890f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">MED 321f</subfield><subfield code="2">stub</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clinical evaluation of tumor-associated trypsin inhibitor (TATI)</subfield><subfield code="b">proceedings of a symposium held in Barcelona on September 24, 1989</subfield><subfield code="c">ed. Ulf-Håkan Stenman ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford u.a.</subfield><subfield code="b">Blackwell Scientific Publ.</subfield><subfield code="c">1991</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">73 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">The Scandinavian journal of clinical and laboratory investigation / Supplement</subfield><subfield code="v">207</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tumorantigen</subfield><subfield code="0">(DE-588)4186425-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tumorassoziierter Trypsininhibitor</subfield><subfield code="0">(DE-588)4275475-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Tumor</subfield><subfield code="0">(DE-588)4078460-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Trypsininhibitor</subfield><subfield code="0">(DE-588)4186358-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1989</subfield><subfield code="z">Barcelona</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Tumorassoziierter Trypsininhibitor</subfield><subfield code="0">(DE-588)4275475-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Tumor</subfield><subfield code="0">(DE-588)4078460-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Trypsininhibitor</subfield><subfield code="0">(DE-588)4186358-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Tumorantigen</subfield><subfield code="0">(DE-588)4186425-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Trypsininhibitor</subfield><subfield code="0">(DE-588)4186358-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stenman, Ulf-Håkan</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="810" ind1="2" ind2=" "><subfield code="a">Supplement</subfield><subfield code="t"><<The>> Scandinavian journal of clinical and laboratory investigation</subfield><subfield code="v">207</subfield><subfield code="w">(DE-604)BV000003737</subfield><subfield code="9">207</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-002846331</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift 1989 Barcelona gnd-content |
genre_facet | Konferenzschrift 1989 Barcelona |
id | DE-604.BV004636761 |
illustrated | Illustrated |
indexdate | 2024-07-09T16:15:20Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-002846331 |
oclc_num | 58503305 |
open_access_boolean | |
owner | DE-12 DE-19 DE-BY-UBM DE-20 DE-91 DE-BY-TUM DE-355 DE-BY-UBR DE-29 |
owner_facet | DE-12 DE-19 DE-BY-UBM DE-20 DE-91 DE-BY-TUM DE-355 DE-BY-UBR DE-29 |
physical | 73 S. graph. Darst. |
publishDate | 1991 |
publishDateSearch | 1991 |
publishDateSort | 1991 |
publisher | Blackwell Scientific Publ. |
record_format | marc |
series2 | The Scandinavian journal of clinical and laboratory investigation / Supplement |
spelling | Clinical evaluation of tumor-associated trypsin inhibitor (TATI) proceedings of a symposium held in Barcelona on September 24, 1989 ed. Ulf-Håkan Stenman ... Oxford u.a. Blackwell Scientific Publ. 1991 73 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier The Scandinavian journal of clinical and laboratory investigation / Supplement 207 Literaturangaben Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Tumorantigen (DE-588)4186425-6 gnd rswk-swf Tumorassoziierter Trypsininhibitor (DE-588)4275475-6 gnd rswk-swf Tumor (DE-588)4078460-5 gnd rswk-swf Trypsininhibitor (DE-588)4186358-6 gnd rswk-swf (DE-588)1071861417 Konferenzschrift 1989 Barcelona gnd-content Tumorassoziierter Trypsininhibitor (DE-588)4275475-6 s Krebs Medizin (DE-588)4073781-0 s DE-604 Tumor (DE-588)4078460-5 s Trypsininhibitor (DE-588)4186358-6 s Tumorantigen (DE-588)4186425-6 s Stenman, Ulf-Håkan Sonstige oth Supplement <<The>> Scandinavian journal of clinical and laboratory investigation 207 (DE-604)BV000003737 207 |
spellingShingle | Clinical evaluation of tumor-associated trypsin inhibitor (TATI) proceedings of a symposium held in Barcelona on September 24, 1989 Krebs Medizin (DE-588)4073781-0 gnd Tumorantigen (DE-588)4186425-6 gnd Tumorassoziierter Trypsininhibitor (DE-588)4275475-6 gnd Tumor (DE-588)4078460-5 gnd Trypsininhibitor (DE-588)4186358-6 gnd |
subject_GND | (DE-588)4073781-0 (DE-588)4186425-6 (DE-588)4275475-6 (DE-588)4078460-5 (DE-588)4186358-6 (DE-588)1071861417 |
title | Clinical evaluation of tumor-associated trypsin inhibitor (TATI) proceedings of a symposium held in Barcelona on September 24, 1989 |
title_auth | Clinical evaluation of tumor-associated trypsin inhibitor (TATI) proceedings of a symposium held in Barcelona on September 24, 1989 |
title_exact_search | Clinical evaluation of tumor-associated trypsin inhibitor (TATI) proceedings of a symposium held in Barcelona on September 24, 1989 |
title_full | Clinical evaluation of tumor-associated trypsin inhibitor (TATI) proceedings of a symposium held in Barcelona on September 24, 1989 ed. Ulf-Håkan Stenman ... |
title_fullStr | Clinical evaluation of tumor-associated trypsin inhibitor (TATI) proceedings of a symposium held in Barcelona on September 24, 1989 ed. Ulf-Håkan Stenman ... |
title_full_unstemmed | Clinical evaluation of tumor-associated trypsin inhibitor (TATI) proceedings of a symposium held in Barcelona on September 24, 1989 ed. Ulf-Håkan Stenman ... |
title_short | Clinical evaluation of tumor-associated trypsin inhibitor (TATI) |
title_sort | clinical evaluation of tumor associated trypsin inhibitor tati proceedings of a symposium held in barcelona on september 24 1989 |
title_sub | proceedings of a symposium held in Barcelona on September 24, 1989 |
topic | Krebs Medizin (DE-588)4073781-0 gnd Tumorantigen (DE-588)4186425-6 gnd Tumorassoziierter Trypsininhibitor (DE-588)4275475-6 gnd Tumor (DE-588)4078460-5 gnd Trypsininhibitor (DE-588)4186358-6 gnd |
topic_facet | Krebs Medizin Tumorantigen Tumorassoziierter Trypsininhibitor Tumor Trypsininhibitor Konferenzschrift 1989 Barcelona |
volume_link | (DE-604)BV000003737 |
work_keys_str_mv | AT stenmanulfhakan clinicalevaluationoftumorassociatedtrypsininhibitortatiproceedingsofasymposiumheldinbarcelonaonseptember241989 |